Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

2.770 +0.570 (+25.91%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,692,264
Open 2.210
Bid (Size) 2.570 (900)
Ask (Size) 2.670 (100)
Prev. Close 2.200
Today's Range 2.190 - 2.810
52wk Range 0.2404 - 3.672
Shares Outstanding 17,472,986
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga

Performance

YTD
+515.4%
+515.4%
1 Month
+33.2%
+33.2%
3 Month
+386.8%
+386.8%
6 Month
+675.5%
+675.5%
1 Year
-19.0%
-19.0%

More News

Read More
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Top movers in Friday's session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Top movers in Tuesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session.
Via Chartmill

Frequently Asked Questions

Is Relmada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?
Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?
The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market
What is the current price of Relmada Therapeutics, Inc. - Common Stock?
The current price of Relmada Therapeutics, Inc. - Common Stock is 2.770
When was Relmada Therapeutics, Inc. - Common Stock last traded?
The last trade of Relmada Therapeutics, Inc. - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?
The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 48.40M
How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?
Relmada Therapeutics, Inc. - Common Stock has 48M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.